Skip to main navigation

Hit enter to search or ESC to close

About
Platform
Programs & Research
- Pipeline & Programs
- Publications & Presentations
Investors
Advocacy / Partnerships

Events & Presentations

Menu

Press Releases
Events & Presentations

Presentations

March 2026

Corporate Presentation

Upcoming Events

There are no upcoming events scheduled at this time.

Past Events

February 24, 2026 8:00 AM EST

Palvella Therapeutics Conference Call to Discuss Topline Results from the Phase 3 SELVA Study

Presentation

December 15, 2025 8:30 AM EST

Palvella Therapeutics Conference Call to Discuss Topline Results from the Phase 2 TOIVA study

Presentation

November 12, 2025 4:00 PM EST

Stifel 2025 Healthcare Conference

November 11, 2025 8:30 AM EST

Palvella’s Third Quarter 2025 Financial Results and Corporate Update Conference Call

Palvella Therapeutics Q3 2025 Earnings Call Presentation

November 5, 2025 8:30 AM EST

Palvella Therapeutics Conference Call to Discuss New Product Candidate QTORIN™ Pitavastatin for Disseminated Superficial Actinic Porokeratosis

Presentation

September 24, 2025 8:30 AM EDT

Palvella Therapeutics Conference Call to Discuss Expansion of QTORIN™ Rapamycin Pipeline to Include Clinically Significant Angiokeratomas

Presentations

September 8, 2025 10:30 AM EDT

H.C. Wainwright 27th Annual Global Investment Conference

September 4, 2025 2:45 PM EDT

Cantor Global Healthcare Conference

August 14, 2025 8:30 AM EDT

Palvella’s Second 2025 Financial Results and Corporate Update Conference Call

Click here for Webcast

Q2 2025 Earnings Presentation

August 12, 2025 1:00 PM EDT

CG 45th Annual Growth Conference

Click here for Webcast

Current page 1
Page 2
Next page
Last page

© 2026 Palvella Therapeutics.

Close Menu

About
Platform
Programs & Research
- Pipeline & Programs
- Publications & Presentations
Investors
Advocacy / Partnerships

Search Investors

Search this site